- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.12.25 | Tivic Acquires Scorpius Manufacturing Assets And Secures More Than $90 Million Financing | 1 | pulse2.com | ||
| 11.12.25 | Tivic Health Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 11.12.25 | Tivic Health übernimmt Produktionsanlagen und gründet CDMO-Tochtergesellschaft | 2 | Investing.com Deutsch | ||
| TIVIC HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 11.12.25 | Tivic Health acquires manufacturing assets, launches CDMO subsidiary | 6 | Investing.com | ||
| 11.12.25 | Tivic Health Systems: Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package | 332 | ACCESS Newswire | Acquisition creates additional near-term revenue opportunities from newly formed Contract Development and Manufacturing Organization (CDMO) subsidiary, Velocity BioworksFinancing led by 3i, LP includes... ► Artikel lesen | |
| 18.11.25 | Tivic Health Systems: Tivic Secures Barda Meeting for Entolimod for Acute Radiation Syndrome | 360 | ACCESS Newswire | Meeting with Radiological and Nuclear Medical Countermeasures Program FREMONT, CA / ACCESS Newswire / November 18, 2025 / Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage therapeutics company... ► Artikel lesen | |
| 14.11.25 | Earnings Call: Strategiewechsel bei Tivic Health Systems belastet Ergebnis und Aktie | 1 | Investing.com Deutsch | ||
| 14.11.25 | Tivic Health Systems GAAP EPS of -$1.97, revenue of $0.15M | 4 | Seeking Alpha | ||
| 14.11.25 | Tivic Health Systems: Tivic Reports Third Quarter 2025 Financial Results | 2.026 | ACCESS Newswire | Continues Execution of Strategic Transformation and Advancement of Biologics Pipeline FREMONT, CA / ACCESS Newswire / November 14, 2025 / Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified immunotherapeutics... ► Artikel lesen | |
| 13.11.25 | Tivic Health erzielt Fortschritte bei der Optimierung der Nervenstimulation | 1 | Investing.com Deutsch | ||
| 13.11.25 | Tivic Health optimizes nerve stimulation parameters in new study | 3 | Investing.com | ||
| 13.11.25 | Tivic Health Systems: Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation | 267 | ACCESS Newswire | The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire / November 13, 2025 / Tivic Health Systems, Inc.... ► Artikel lesen | |
| 13.11.25 | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.11.25 | Tivic Health files two new patents for cancer and bioelectronic therapies | 1 | Investing.com | ||
| 10.11.25 | Tivic Health erweitert Patentportfolio für Krebs- und bioelektronische Therapien | 1 | Investing.com Deutsch | ||
| 17.10.25 | Tivic Health files to sell 1.58M shares of common stock for holders | 1 | Seeking Alpha | ||
| 15.10.25 | Tivic Health Systems und CEO Jennifer Ernst vereinbaren neuen Anstellungsvertrag | 1 | Investing.com Deutsch | ||
| 15.10.25 | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.08.25 | Tivic Health Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08.25 | Tivic Health receives two INDs for Entolimod from Statera Biopharma | 11 | Investing.com |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTELLIGENT BIO SOLUTIONS | 9,530 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| BETA BIONICS | 30,470 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 130,06 | +1,61 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| HEARTFLOW | 29,150 | -3,51 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,760 | +2,70 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,170 | -2,62 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| SIGHT SCIENCES | 7,930 | -0,88 % | Sight Sciences, Inc.: Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer | MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,450 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| OPTIMIZERX | 12,260 | -1,05 % | OptimizeRx Corporation: OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising | Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar's Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept.... ► Artikel lesen | |
| CERIBELL | 21,930 | 0,00 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| EKSO BIONICS | 8,640 | 0,00 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 31,460 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| RXSIGHT | 10,420 | 0,00 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| PROGYNY | 25,690 | -0,58 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BILLIONTOONE | 81,73 | -3,95 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
Das Unternehmen TIVIC HEALTH SYSTEMS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -7,64 % bei einem Aktienkurs von 1,450 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TIVIC HEALTH SYSTEMS INC finden Sie auf Wallstreet Online.